Siren, L.L.C
$3.6B Assets Reported
132 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | 10,825,013 | $532M | 14.8% |
| KYMR | Kymera Therapeutics Inc | 3,186,830 | $265M | 7.4% |
| ERAS | Erasca Inc | 11,244,246 | $182M | 5.0% |
| EWTX | Edgewise Therapeutics Inc | 4,430,263 | $140M | 3.9% |
| ONC | BeOne Medicines AG | 465,000 | $138M | 3.8% |
| TNGX | Tango Therapeutics Inc | 5,657,105 | $118M | 3.3% |
| BCAX | Bicara Therapeutics Inc | 5,802,970 | $115M | 3.2% |
| RVMD | Revolution Medicines Inc | 1,110,980 | $108M | 3.0% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1,615,476 | $101M | 2.8% |
| MANE | Veradermics Inc | 1,505,374 | $95M | 2.6% |
Track Siren, L.L.C's 13F portfolio: $3.6B in reported holdings, 132 positions. Top holdings, AUM, and quarterly changes on SentiSense.